Propofol Requirement for Induction of Unconsciousness Is Reduced in Patients with Parkinson's Disease: A Case Control Study

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease, but whether the neurodegenerative process influences the pharmacodynamics of propofol remains unclear. We aimed to evaluate the effect of PD on pharmacodynamics of propofol. A total of 31 PD patients undergoing sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao-ping, Yu, Xi-ya, Wu, Xi, Hu, Xiao-wu, Chen, Jian-chun, Li, Jin-bao, Wang, Jia-feng, Deng, Xiao-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606158/
https://www.ncbi.nlm.nih.gov/pubmed/26495319
http://dx.doi.org/10.1155/2015/953729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606158/
https://www.ncbi.nlm.nih.gov/pubmed/26495319
http://dx.doi.org/10.1155/2015/953729

Ejemplares similares